220 related articles for article (PubMed ID: 36080177)
21. High expression of Helicobacter pylori VapD in both the intracellular environment and biopsies from gastric patients with severity.
Morales-Espinosa R; Delgado G; Serrano LR; Castillo E; Santiago CA; Hernández-Castro R; Gonzalez-Pedraza A; Mendez JL; Mundo-Gallardo LF; Manzo-Merino J; Ayala S; Cravioto A
PLoS One; 2020; 15(3):e0230220. PubMed ID: 32163505
[TBL] [Abstract][Full Text] [Related]
22. Presence of iceA1 but not cagA, cagC, cagE, cagF, cagN, cagT, or orf13 genes of Helicobacter pylori is associated with more severe gastric inflammation in Taiwanese.
Sheu SM; Sheu BS; Yang HB; Li C; Chu TC; Wu JJ
J Formos Med Assoc; 2002 Jan; 101(1):18-23. PubMed ID: 11911033
[TBL] [Abstract][Full Text] [Related]
23. [Difference analysis on proteome of Helicobacter pylori in patients with peptic ulcer, gastritis, and gastric cancer].
Zhang J; Ding SG; Zhong LJ; Lin SR; Yang B; Peng JR; Lou YX
Zhonghua Yi Xue Za Zhi; 2006 Oct; 86(38):2690-4. PubMed ID: 17199978
[TBL] [Abstract][Full Text] [Related]
24. Helicobacter pylori promotes the expression of Krüppel-like factor 5, a mediator of carcinogenesis, in vitro and in vivo.
Noto JM; Khizanishvili T; Chaturvedi R; Piazuelo MB; Romero-Gallo J; Delgado AG; Khurana SS; Sierra JC; Krishna US; Suarez G; Powell AE; Goldenring JR; Coffey RJ; Yang VW; Correa P; Mills JC; Wilson KT; Peek RM
PLoS One; 2013; 8(1):e54344. PubMed ID: 23372710
[TBL] [Abstract][Full Text] [Related]
25. Helicobacter pylori cag pathogenicity island is associated with enhanced interleukin-8 expression in human gastric mucosa.
Orsini B; Ciancio G; Censini S; Surrenti E; Pellegrini G; Milani S; Herbst H; Amorosi A; Surrenti C
Dig Liver Dis; 2000; 32(6):458-67. PubMed ID: 11057919
[TBL] [Abstract][Full Text] [Related]
26. Micronutrient antioxidants in gastric mucosa and serum in patients with gastritis and gastric ulcer: does Helicobacter pylori infection affect the mucosal levels?
Nair S; Norkus EP; Hertan H; Pitchumoni CS
J Clin Gastroenterol; 2000 Jun; 30(4):381-5. PubMed ID: 10875465
[TBL] [Abstract][Full Text] [Related]
27. Helicobacter pylori associated gastric diseases and lymphoid tissue hyperplasia in gastric antral mucosa.
Chen XY; Liu WZ; Shi Y; Zhang DZ; Xiao SD; Tytgat GN
J Clin Pathol; 2002 Feb; 55(2):133-7. PubMed ID: 11865009
[TBL] [Abstract][Full Text] [Related]
28. Prevalence of Helicobacter pylori in southern Indian controls and patients with gastroduodenal disease.
Prasad S; Mathan M; Chandy G; Rajan DP; Venkateswaran S; Ramakrishna BS; Mathan VI
J Gastroenterol Hepatol; 1994; 9(5):501-6. PubMed ID: 7827302
[TBL] [Abstract][Full Text] [Related]
29. Difference of p53AIP1 mRNA expression in gastric mucosa between patients with gastric cancer and chronic gastritis infected with Helicobacter pylori.
Sawaya M; Yoshimura T; Shimoyama T; Munakata A; Fukuda S
J Clin Gastroenterol; 2008 Apr; 42(4):351-5. PubMed ID: 18277906
[TBL] [Abstract][Full Text] [Related]
30. Microbiota according to gastric topography in patients with low or high risk of gastric cancer in Nariño, Colombia.
Caguazango JC; Pazos ÁJ
Biomedica; 2019 Aug; 39(Supl. 2):157-171. PubMed ID: 31529842
[TBL] [Abstract][Full Text] [Related]
31. Genetic polymorphisms in the cag pathogenicity island of Helicobacter pylori and risk of stomach cancer and high-grade premalignant gastric lesions.
Canzian F; Rizzato C; Obazee O; Stein A; Flores-Luna L; Camorlinga-Ponce M; Mendez-Tenorio A; Vivas J; Trujillo E; Jang H; Chen W; Kasamatsu E; Bravo MM; Torres J; Muñoz N; Kato I
Int J Cancer; 2020 Nov; 147(9):2437-2445. PubMed ID: 32363734
[TBL] [Abstract][Full Text] [Related]
32. Connexin 32 and 43 promoter methylation in Helicobacter pylori-associated gastric tumorigenesis.
Wang Y; Huang LH; Xu CX; Xiao J; Zhou L; Cao D; Liu XM; Qi Y
World J Gastroenterol; 2014 Sep; 20(33):11770-9. PubMed ID: 25206281
[TBL] [Abstract][Full Text] [Related]
33. Role of Helicobacter pylori in gastric carcinoma.
Prabhu SR; Amrapurkar AD; Amrapurkar DN
Natl Med J India; 1995; 8(2):58-60. PubMed ID: 7735060
[TBL] [Abstract][Full Text] [Related]
34. The Role of E-cadherin in Helicobacter pylori-Related Gastric Diseases.
Zhang Y; Li D; Dai Y; Li R; Gao Y; Hu L
Curr Drug Metab; 2019; 20(1):23-28. PubMed ID: 29938616
[TBL] [Abstract][Full Text] [Related]
35. Cancer precursor lesions in intact stomach Helicobacter pylori gastritis and in resected stomach gastritis.
Giuliani A; Spada S; Corona M; Demoro M; Di Bari M; Ricciardulli T; Galati G; Caporale A; Tocchi A; Angelico F
J Exp Clin Cancer Res; 2003 Sep; 22(3):371-8. PubMed ID: 14582693
[TBL] [Abstract][Full Text] [Related]
36. Helicobacter heilmannii gastritis: association with acid peptic diseases and comparison with Helicobacter pylori gastritis.
Jhala D; Jhala N; Lechago J; Haber M
Mod Pathol; 1999 May; 12(5):534-8. PubMed ID: 10349993
[TBL] [Abstract][Full Text] [Related]
37. [Impact of Helicobacter pylori eradication on morphological changes in gastric mucosa].
Pimanov SI; Makarenko EV; Krylov IuV; Matveenko ME; Malashenko SV; Bondarenko VM
Arkh Patol; 2006; 68(5):22-7. PubMed ID: 17144526
[TBL] [Abstract][Full Text] [Related]
38. Response of IgG1 and IgG2 subclasses to Helicobacter pylori in subjects with chronic inflammation of the gastric mucosa, atrophy and gastric cancer in a country with high Helicobacter pylori infection prevalence.
Vorobjova T; Ren Z; Dunkley M; Clancy R; Maaroos HI; Labotkin R; Kull K; Uibo R
APMIS; 2006 May; 114(5):372-80. PubMed ID: 16725014
[TBL] [Abstract][Full Text] [Related]
39. Gastric expression of IL-17A and IFNγ in Helicobacter pylori infected individuals is related to symptoms.
Adamsson J; Ottsjö LS; Lundin SB; Svennerholm AM; Raghavan S
Cytokine; 2017 Nov; 99():30-34. PubMed ID: 28683359
[TBL] [Abstract][Full Text] [Related]
40. Endoscopic findings and prevalence of Helicobacter pylori in Kenyan patients with dyspepsia.
Ogutu EO; Kang'ethe SK; Nyabola L; Nyong'o A
East Afr Med J; 1998 Feb; 75(2):85-9. PubMed ID: 9640829
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
